A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers
Condition(s):Healthy Adult SubjectsLast Updated:January 14, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Healthy Adult SubjectsLast Updated:January 14, 2014Completed
Condition(s):ADHDLast Updated:April 20, 2012Completed
Condition(s):Fragile X SyndromeLast Updated:July 6, 2016Completed
Condition(s):ADHD Predominantly Inattentive TypeLast Updated:January 14, 2014Completed
Condition(s):ADHD, Predominantly Inattentive TypeLast Updated:March 4, 2015Completed
Condition(s):ADHD; Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeLast Updated:March 28, 2017Completed
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:January 19, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.